Figure 4
Figure 4. Wnt/β-catenin-mediated effects on proliferation are affected by Aurora kinase A levels. (A) Wnt3A CM stimulation of MM1.S cells shows increased β-catenin and AurKA levels. MM1.S cells stably overexpressing β-catenin show increased AurKA levels (B) and enhanced proliferation (C). (D) Immunoblot of stable AurKA shRNA knockdown in MM1.S cells. (E) Cell-cycle profiling of control or AurKA shRNA MM1.S cells show increased G2/M phase. (F) AurKA knockdown in MM1.S decreased proliferation. (G) AurKA shRNA counteracts the positive proliferative effect of β-catenin overexpression or Wnt3A CM stimulation (H). Control (Control GFP) or β-catenin overexpressing cells (β-catenin GFP) were stably transduced with control (■) or AurKA shRNA ([graphic024]) and assayed for proliferation. Proliferation experiments were done in triplicate and repeated twice. The results denote the average and SEM of triplicate assays.

Wnt/β-catenin-mediated effects on proliferation are affected by Aurora kinase A levels. (A) Wnt3A CM stimulation of MM1.S cells shows increased β-catenin and AurKA levels. MM1.S cells stably overexpressing β-catenin show increased AurKA levels (B) and enhanced proliferation (C). (D) Immunoblot of stable AurKA shRNA knockdown in MM1.S cells. (E) Cell-cycle profiling of control or AurKA shRNA MM1.S cells show increased G2/M phase. (F) AurKA knockdown in MM1.S decreased proliferation. (G) AurKA shRNA counteracts the positive proliferative effect of β-catenin overexpression or Wnt3A CM stimulation (H). Control (Control GFP) or β-catenin overexpressing cells (β-catenin GFP) were stably transduced with control (■) or AurKA shRNA ([graphic024]) and assayed for proliferation. Proliferation experiments were done in triplicate and repeated twice. The results denote the average and SEM of triplicate assays.

Close Modal

or Create an Account

Close Modal
Close Modal